Press Releases Items Per Page 102550 Year None20242023202220212020201920182017201620152014 02-22-2024 Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting 01-31-2024 Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024 01-26-2024 Daré Bioscience Announces Executive Team and Board of Directors Changes 01-17-2024 Daré Bioscience Announces Grant to Support Biotherapeutic Product Development 01-04-2024 Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 15 of 15
02-22-2024 Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting
01-31-2024 Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024
01-04-2024 Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases